Join Our Free Breakfast Briefing: How will Artificial Intelligence and Machine Learning Impact the Pharma Regulatory and Medical Affairs Space? 5 Mar 2024
PharmaMedic is delighted to announce our next virtual breakfast briefing on Wednesday 24th April, 2024 at 8am (GMT). In this briefing, we will be discussing machine learning and artificial intelligence and a discussion on how this technology may impact our day-to-day roles. Our presenters will draw on their decades of experience supporting pharma, start-ups and biotech companies and their depth of knowledge in Regulatory and Medical Affairs.
Machine learning and AI has suddenly become a “go to” key technology in our professional and personal lives.
We are delighted to welcome as speakers Dr Malcolm Barratt-Johnson, Managing Director at PharmaMedic Consultancy and Dr Christine Grew, Director of Regulatory Affairs, at Canopy Life Sciences. Our expert presenters will consider how Regulatory and Medical Affairs will be impacted by this innovative advancement in processing. The session will consist of both speaker sessions and an opportunity for an interactive Q&A.
The format for the webinar will be as follows:
Welcome and Introductions: Dr Malcolm Barratt-Johnson, Managing Director, PharmaMedic Consultancy
Topic 1 – How will Artificial Intelligence and Machine Learning revolutionise the Drug Development and Regulatory paradigm? – Dr Christine Grew, Director of Regulatory Affairs at Canopy Life Sciences.
Topic 2 – How will Medical Affairs implement the widespread application of Artificial Intelligence and Machine Learning – Dr Malcolm Barratt-Johnson, Managing Director at PharmaMedic Consultancy.
Q&A will follow.
This webinar is designed to offer an easily accessible format for busy pharmaceutical professionals and will conclude before your 9am meetings.
Register here to attend, and feel free to forward the details to your colleagues.
Can’t attend live? Please still register and we’ll send you the recording after the webinar.
About our speakers:
Dr Malcolm Barratt-Johnson, Bsc, (Hons), MBBS
Malcolm is the Managing Director of PharmaMedic and its Senior Consultant. He has over 18 years of experience as a UK / European based Consultant Pharmaceutical Physician to Industry and Government, specialising in Medical Affairs, Product Development and Regulatory Strategy.
Dr Christine Grew
Christine is a scientific communicator, business leader and performance coach with over 20 years of wide-ranging drug development and regulatory affairs experience. Christine has led regulatory projects for small and large pharma/biotech/CDMO’s and through regulatory consultancy practice. Christine is also a performance, communication and leadership coach and facilitator.